[1]
C. Cordero-García and M. del Mar Sáenz de Tejada Sánchez, “Benefit and safety of incobotulinumtoxina for early management of post-stroke spasticity in a patient with SARS-CoV-2: A case report”, JRM-CC, vol. 4, pp. 1–4, Jun. 2021.